Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for iTeos Therapeutics Inc have a median target of 33.50, with a high estimate of 47.00 and a low estimate of 22.00. The median estimate represents a 312.05% increase from the last price of 8.13.
High | 478.1% | 47.00 |
Med | 312.1% | 33.50 |
Low | 170.6% | 22.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 04, 2025.
Average growth rate | -105.12% |
Average growth rate | -54.93% |
More ▼
Revenue history & estimates in USD
Average growth rate | -33.33% |
Average growth rate | -58.83% |
More ▼